Elevai Labs Past Earnings Performance
Past criteria checks 0/6
Elevai Labs's earnings have been declining at an average annual rate of -46.8%, while the Personal Products industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 69.3% per year.
Key information
-46.8%
Earnings growth rate
-34.4%
EPS growth rate
| Personal Products Industry Growth | 20.9% |
| Revenue growth rate | 69.3% |
| Return on equity | -63.9% |
| Net Margin | -223.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elevai Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2 | -5 | 6 | 0 |
| 30 Jun 24 | 2 | -5 | 6 | 0 |
| 31 Mar 24 | 2 | -5 | 5 | 0 |
| 31 Dec 23 | 2 | -4 | 4 | 0 |
| 30 Sep 23 | 1 | -4 | 4 | 0 |
| 30 Jun 23 | 1 | -4 | 3 | 0 |
| 31 Mar 23 | 1 | -3 | 2 | 0 |
| 31 Dec 22 | 1 | -2 | 2 | 0 |
| 31 Dec 21 | 0 | -1 | 1 | 0 |
Quality Earnings: ELAB is currently unprofitable.
Growing Profit Margin: ELAB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ELAB is unprofitable, and losses have increased over the past 5 years at a rate of 46.8% per year.
Accelerating Growth: Unable to compare ELAB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ELAB is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (-5.2%).
Return on Equity
High ROE: ELAB has a negative Return on Equity (-63.92%), as it is currently unprofitable.